Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 16Plasma cell 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Venous Thromboembolism 1Glioma 1Dyskinesias 1

Interventions

apixaban 1Tinzaparin 1Rivaroxaban 1Long-Term Synaptic Depression 1Dalteparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Rivaroxaban × CNS × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡